Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

Myriad Genetics (NASDAQ: MYGN) will release its fourth quarter and full year 2025 financial results and hold an earnings conference call at 4:30 pm ET on Monday, Feb. 23, 2026.

Rhea-AI Summary

Myriad Genetics (NASDAQ: MYGN) will release its fourth quarter and full year 2025 financial results and hold an earnings conference call at 4:30 pm ET on Monday, Feb. 23, 2026. The earnings release will be issued after market close the same day.

Management will provide a financial overview and business update; a live webcast and archived replay will be available at the company's Investor Relations website. Company executives will also appear at three investor healthcare conferences in March 2026.

Argus Feb 17 session

+0.22% close to close Open Argus

Details

News Market Reaction – MYGN

In the Feb 17 session, MYGN gained 0.22%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules Myriad’s fourth quarter and full year 2025 earnings call for February 23...

Analysis

This announcement schedules Myriad’s fourth quarter and full year 2025 earnings call for February 23, 2026 at 4:30 pm ET and outlines participation in three healthcare investor conferences in early March. It adds to a steady cadence of recent updates on MRD commercialization, preliminary 2025 results, and clinical data. Investors may focus on the final audited figures versus January’s preliminary ranges and any changes to 2026 guidance or strategic priorities discussed on the call.

Key Figures

Earnings call time: 4:30 pm ET Earnings release date: February 23, 2026 Investor conferences count: 3 conferences +3 more

Earnings call time

4:30 pm ET

Q4 and full year 2025 earnings conference call on Feb 23, 2026

Earnings release date

February 23, 2026

Fourth quarter and full year 2025 results release after market close

Investor conferences count

3 conferences

Upcoming healthcare investor conferences with management participation

TD Cowen presentation

3:10 pm ET, March 3, 2026

Fireside chat at TD Cowen 46th Annual Health Care Conference

Leerink presentation

1:40 pm ET, March 10, 2026

Fireside chat at Leerink Partners Global Healthcare Conference

Barclays conference date

March 11, 2026

1-on-1 meetings at Barclays 28th Annual Global Healthcare Conference

Historical Context

5 past events · Latest: Jan 27

5 events

1. Jan 27

   MRD launch update

   24h Move

   +1.9%

   Planned Precise MRD launch with strong ctDNA sensitivity data.

2. Jan 12

   Prelim results & guide

   24h Move

   -0.1%

   Preliminary 2025 revenue ranges and 2026 revenue/EBITDA guidance.

3. Jan 05

   Conference presentation

   24h Move

   +0.0%

   J.P. Morgan Healthcare Conference presentation announcement and webcast details.

4. Dec 09

   SABCS abstracts

   24h Move

   +4.0%

   Eight SABCS abstracts on MRD, hereditary cancer, and risk testing.

5. Nov 25

   AI risk platform

   24h Move

   -3.9%

   Launch of integrated AI and genetic breast cancer risk platform.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Management will participate in three upcoming investor healthcare conferences

SALT LAKE CITY, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular testing and precision medicine, will hold its fourth quarter and full year 2025 earnings conference call at 4:30 pm ET on Monday, Feb. 23, 2026. The company’s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company’s performance for the fourth quarter and full year 2025.

A live webcast of the earnings conference call can be accessed on Myriad’s Investor Relations website at investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at investor.myriad.com following the call.

Upcoming Investor Conferences
Sam Raha, President and CEO, and Ben Wheeler, Chief Financial Officer, will participate in the following investor healthcare conferences:

• The TD Cowen 46th Annual Health Care Conference in a fireside chat at 3:10 pm ET on Tuesday, March 3, 2026.
• The Leerink Partners Global Healthcare Conference in a fireside chat at 1:40 pm ET on Tuesday, March 10, 2026.
• The Barclays 28^th Annual Global Healthcare conference in 1-on-1 meetings on Wednesday, March 11, 2026.
  

Live and archived webcasts of presentations at TD Cowen and Leerink Partners can be viewed at investor.myriad.com.

About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Investor Contact 
Matt Scalo 
(801) 584-3532 
IR@myriad.com 

Media Contact 
Kate Schraml
(385) 318-3718 
PR@myriad.com  

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Myriad Genetics (MYGN) release Q4 and full year 2025 results and hold the earnings call?

Myriad will release results and hold an earnings call on Feb. 23, 2026 at 4:30 pm ET. According to the company, the earnings release is scheduled after market close and a live webcast will be available on its Investor Relations website.

How can investors access Myriad Genetics (MYGN) live earnings webcast on Feb. 23, 2026?

Investors can access the live webcast via Myriad's Investor Relations website at investor.myriad.com. According to the company, the webcast will stream live during the call and an archived replay will be posted following the event.

Can investors join Myriad Genetics (MYGN) earnings call by telephone and how do they register?

Yes, telephone participation requires registration to receive a dial-in number and unique PIN. According to the company, registrants will be provided the dial-in details and PIN after completing the registration link.

Which Myriad Genetics executives will speak at investor conferences in March 2026?

Sam Raha, President and CEO, and Ben Wheeler, Chief Financial Officer, will participate in March 2026 conferences. According to the company, they will appear at TD Cowen, Leerink Partners, and Barclays investor healthcare events with live or archived webcasts available.

When and where will Myriad present at the TD Cowen healthcare conference in March 2026?

Myriad's presentation at TD Cowen is scheduled for 3:10 pm ET on Tuesday, March 3, 2026 as a fireside chat. According to the company, a live webcast and archived replay will be accessible on its Investor Relations website.

Will Myriad Genetics (MYGN) provide archived webcasts of the March 2026 investor presentations?

Yes, archived webcasts will be posted on the company's Investor Relations website. According to the company, presentations from TD Cowen and Leerink Partners will be available live and as archived replays at investor.myriad.com.